| The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? LM Hamberg, GJ Hunter, NM Alpert, NC Choi, JW Babich, AJ Fischman Journal of Nuclear Medicine 35 (8), 1308-1312, 1994 | 538 | 1994 |
| Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy CM Zechmann, A Afshar-Oromieh, T Armor, JB Stubbs, W Mier, ... European journal of nuclear medicine and molecular imaging 41, 1280-1292, 2014 | 421 | 2014 |
| Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer SM Hillier, KP Maresca, FJ Femia, JC Marquis, CA Foss, N Nguyen, ... Cancer research 69 (17), 6932-6940, 2009 | 410 | 2009 |
| A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer KP Maresca, SM Hillier, FJ Femia, D Keith, C Barone, JL Joyal, ... Journal of medicinal chemistry 52 (2), 347-357, 2009 | 397 | 2009 |
| A ticket to ride: peptide radiopharmaceuticals AJ Fischman, JW Babich, HW Strauss Journal of Nuclear Medicine 34 (12), 2253-2263, 1993 | 302 | 1993 |
| 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer SM Hillier, KP Maresca, G Lu, RD Merkin, JC Marquis, CN Zimmerman, ... Journal of Nuclear Medicine 54 (8), 1369-1376, 2013 | 296 | 2013 |
| First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer JA Barrett, RE Coleman, SJ Goldsmith, S Vallabhajosula, NA Petry, S Cho, ... Journal of Nuclear Medicine 54 (3), 380-387, 2013 | 290 | 2013 |
| Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer Y Chen, CA Foss, Y Byun, S Nimmagadda, M Pullambhatla, JJ Fox, ... Journal of medicinal chemistry 51 (24), 7933-7943, 2008 | 278 | 2008 |
| The rise of PSMA ligands for diagnosis and therapy of prostate cancer A Afshar-Oromieh, JW Babich, C Kratochwil, FL Giesel, M Eisenhut, ... Journal of Nuclear Medicine 57 (Supplement 3), 79S-89S, 2016 | 256 | 2016 |
| Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules PA Netti, LM Hamberg, JW Babich, D Kierstead, W Graham, GJ Hunter, ... Proceedings of the National Academy of Sciences 96 (6), 3137-3142, 1999 | 248 | 1999 |
| Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies KA Stephenson, SR Banerjee, T Besanger, OO Sogbein, MK Levadala, ... Journal of the American Chemical Society 126 (28), 8598-8599, 2004 | 247 | 2004 |
| New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design SR Banerjee, KP Maresca, L Francesconi, J Valliant, JW Babich, ... Nuclear medicine and biology 32 (1), 1-20, 2005 | 225 | 2005 |
| Bifunctional Single Amino Acid Chelates for Labeling of Biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ Cores. Crystal and Molecular Structures of [ReBr(CO)3(H2NCH2C5H4N)], [Re(CO)3{(C5H4NCH2)2NH}]Br, [Re(CO)3{(C5H4NCH2)2NCH2CO2H}]Br, [Re(CO)3{X(Y)NCH2CO2CH2CH3}]Br (X = Y = 2-pyridylmethyl; X = 2 … SR Banerjee, MK Levadala, N Lazarova, L Wei, JF Valliant, ... Inorganic Chemistry 41 (24), 6417-6425, 2002 | 222 | 2002 |
| An eighteen‐membered macrocyclic ligand for actinium‐225 targeted alpha therapy NA Thiele, V Brown, JM Kelly, A Amor‐Coarasa, U Jermilova, ... Angewandte Chemie International Edition 56 (46), 14712-14717, 2017 | 205 | 2017 |
| Metabolic Imaging With β-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia V Dilsizian, TM Bateman, SR Bergmann, R Des Prez, MY Magram, ... Circulation 112 (14), 2169-2174, 2005 | 205 | 2005 |
| New strategies in prostate cancer: prostate-specific membrane antigen (PSMA) ligands for diagnosis and therapy U Haberkorn, M Eder, K Kopka, JW Babich, M Eisenhut Clinical Cancer Research 22 (1), 9-15, 2016 | 204 | 2016 |
| PSMA as a target for radiolabelled small molecules M Eder, M Eisenhut, J Babich, U Haberkorn European journal of nuclear medicine and molecular imaging 40, 819-823, 2013 | 197 | 2013 |
| A convenient synthesis, chemical characterization and reactivity of [Re (CO) 3 (H2O) 3] Br: the crystal and molecular structure of [Re (CO) 3 (CH3CN) 2Br] N Lazarova, S James, J Babich, J Zubieta Inorganic Chemistry Communications 7 (9), 1023-1026, 2004 | 190 | 2004 |
| Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection JW Babich, H Solomon, MC Pike, D Kroon, W Graham, MJ Abrams, ... Journal of Nuclear Medicine 34 (11), 1964-1974, 1993 | 188 | 1993 |
| Glu-ureido–based inhibitors of prostate-specific membrane antigen: lessons learned during the development of a novel class of low-molecular-weight theranostic radiotracers K Kopka, M Benešová, C Bařinka, U Haberkorn, J Babich Journal of Nuclear Medicine 58 (Supplement 2), 17S-26S, 2017 | 180 | 2017 |
Jon ZubietaProfessor of Chemistry Syracuse UniversityVerified email at syr.edu
